Table 1.
Clinical profiles of patients
| No. | Sex | Age (years) | Follow-up period (months) | Operated side | Corticosteroid therapy | Associated disease | Classification | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Before CABMAT | After CABMAT | ||||||||||
| Maximum dose (mg/day) | Pulse | Type | Stage | Type | Stage | ||||||
| 1 | F | 33 | 53 | Bil | 60 | - | HL | C1/C2 | 1/2 | C1/C2 | 2/2 |
| 2 | F | 33 | 52 | Bil | 1,000 | + | APS | C2/C2 | 3B/2 | C2/C2 | 3B/3A |
| 3 | F | 52 | 45 | L | 1,000 | + | HL | C2 | 3B | C2 | 4 |
| 4 | F | 16 | 46 | L | 1,000 | + | - | C1 | 2 | C1 | 2 |
| 5 | F | 37 | 37 | Bil | 60 | - | - | C2/C1 | 3A/2 | C2/C1 | 3A/2 |
| 6 | F | 28 | 37 | R | 1,000 | + | APS | C1 | 1 | C1 | 2 |
F female, Bil bilateral, L left, R right, HL hyperlipidaemia, APS antiphospholipid syndrome